What Is Acute Urinary Retention (AUR) and What Are the Warning Signs?

Acute urinary retention (AUR) is the sudden, painful inability to urinate despite having a full bladder. It is the most serious acute complication of BPH and one of the most common urological emergencies. A man experiencing AUR has typically hours — not days — before bladder and kidney damage begins. Emergency catheterisation is required to drain the bladder and relieve the obstruction.

Warning Signs That AUR Is Imminent

• •Progressively worsening hesitancy over days or weeks — each void taking longer to initiate
• •Dramatically reduced urine output despite urinary frequency — voiding only small volumes
• •Increasing lower abdominal pressure and distension
• •Complete absence of urination for 8+ hours despite fluid intake and the urge to void
• •Severe lower abdominal pain with a palpable, distended bladder

Precipitating Factors — When AUR Strikes

AUR rarely occurs without a precipitating event. The most common triggers in men with pre-existing BPH:

• •Cold weather (increases sympathetic tone, worsening dynamic obstruction)
• •Alcohol consumption (diuresis plus sympathetic activation)
• •Anticholinergic medications (antidepressants, antihistamines, antipsychotics)
• •Immobility after surgery or illness
• •Urinary tract infection (swelling and inflammation worsen obstruction)
• •Constipation (rectal mass compresses the urethra)
• •Delayed voiding (overfilling the bladder beyond its compensatory capacity)

What to Do in AUR — Emergency Response

If you suspect AUR — you cannot urinate despite the urge and have had increasing difficulty for hours — go to the emergency department or call emergency services immediately. This is not a condition to manage at home. Treatment involves urethral catheterisation to drain the bladder (immediate relief), followed by a trial without catheter (TWOC) after alpha-blocker therapy has been started to improve the chance of spontaneous voiding.

AUR Risk Prediction

Several factors identify men at elevated AUR risk who warrant proactive BPH treatment rather than watchful waiting. In a community cohort of 2,115 men in Olmsted County, moderate-to-severe symptoms, a depressed peak flow rate (below 12 mL/s, about 4 times the risk), an enlarged prostate (above 30 mL, about 3 times the risk) and older age were all associated with a higher risk of acute urinary retention [1]:

• •PSA above 1.4 ng/mL (correlates with prostate volume above 30mL)
• •IPSS score above 20
• •Qmax below 10 mL/s
• •Post-void residual above 150mL
• •Prostate volume above 30mL on ultrasound
• •Age above 70 with any combination of the above

What Happens During Emergency Catheterisation

In AUR, emergency catheterisation is performed with a 14–16 French urethral catheter inserted under aseptic technique through the urethra into the bladder. In most cases this provides immediate, dramatic pain relief as the retained urine (often 600–1,200mL) drains within minutes. The catheter is left in situ for 24–72 hours while alpha-blocker therapy is initiated. Most centres now practice early alpha-blocker treatment (tamsulosin 400mcg daily for 2–3 days) before attempting a Trial Without Catheter (TWOC). This pharmacological preparation doubles the success rate of catheter removal compared to immediate TWOC.

After AUR: Preventing Recurrence

A successful TWOC after first AUR is not the clinical endpoint — it is a temporary remission. Without definitive BPH treatment, a large share of men experience re-retention within a year. Men who have experienced AUR require proactive BPH management: continuing alpha-blocker therapy long-term, adding a 5-ARI if prostate volume exceeds 30cc, and being referred for urological assessment to determine whether procedural intervention (TURP, UroLift, Rezūm) is appropriate to prevent recurrence. The ALFAUR trial demonstrated that men treated with alfuzosin after AUR had significantly fewer re-retention episodes than placebo-treated men at 3 months.

Medications That Trigger AUR: The Complete List

• •Anticholinergics (oxybutynin, solifenacin, tolterodine): Reduce detrusor contractility — often prescribed for overactive bladder but dangerous in men with BPH
• •Antihistamines (diphenhydramine, chlorphenamine): Available over the counter; anticholinergic and sympathomimetic effects together are particularly risky
• •Tricyclic antidepressants (amitriptyline, imipramine): Both anticholinergic and alpha-adrenergic effects increase urethral resistance
• •Decongestants (pseudoephedrine, phenylephrine): Alpha-agonist activity tightens bladder neck and prostatic urethra
• •Opioid analgesics: Reduce detrusor contractility centrally — post-surgical opioid use is a common AUR trigger
• •Antipsychotics (haloperidol, olanzapine): Strong anticholinergic activity; particularly high risk with co-existing BPH
• •NSAIDs (high dose): Can impair bladder contractility through prostaglandin inhibition in susceptible men

Long-Term Outcomes After AUR

The occurrence of AUR represents a significant milestone in BPH disease progression. Beyond immediate treatment, men who have experienced AUR are at elevated risk for: chronic urinary retention with permanent detrusor damage; upper tract dilation (hydronephrosis) from chronic back-pressure if not adequately treated; recurrent urinary tract infections from residual urine; and progression to requiring permanent catheterisation or major surgical intervention. Early definitive treatment after first AUR — rather than a watchful waiting approach — is therefore the preferred management strategy in most guidelines. Men who undergo TURP within 3 months of first AUR have significantly better long-term voiding outcomes than those managed conservatively.

What Acute Urinary Retention Actually Is

Acute urinary retention (AUR) is the sudden, painful inability to urinate despite a strong and persistent desire to do so. The bladder is palpably distended and tender — men often describe an overwhelming pressure in the lower abdomen. AUR is distinct from a weak or slow stream: in AUR, no urine passes at all, or only a few drops despite sustained effort. The average bladder capacity at which AUR becomes painful is approximately 400–600mL, though men with chronically enlarged bladders from BPH can tolerate larger volumes before experiencing acute discomfort.

This Is a Medical Emergency

AUR is not a condition to monitor at home or manage with increased fluid intake. If you cannot urinate and your bladder is full, go to the emergency department immediately. Without catheterisation within hours, the distended bladder wall becomes ischaemic, urine backs up into the kidneys (hydronephrosis), and acute kidney injury can develop. Do not call your GP's office and wait for a callback. Do not take a prostate supplement and hope the stream returns. Go directly to the emergency department — relief by catheter takes minutes and prevents serious secondary complications.

Known Trigger Factors for AUR

• •Alcohol consumption: reduces external urethral sphincter coordination and causes acute prostate mucosal swelling
• •Constipation: faecal loading in the rectum compresses the urethra and increases outlet resistance — a frequently overlooked trigger
• •Cold weather: cold-induced sympathetic tone increases alpha-adrenergic tone in the prostate and bladder neck
• •Anticholinergic medications: antihistamines (diphenhydramine), overactive bladder drugs (oxybutynin), antidepressants (amitriptyline), and antipsychotics all impair detrusor contractility
• •Spinal or epidural anaesthesia: temporary abolition of detrusor reflexes — AUR is common in the 12 hours after spinal procedures
• •High fluid load: rapid oral or IV fluid loading overwhelms a bladder already functioning at reduced capacity
• •Urinary tract infection: inflammation increases outlet resistance in already narrowed prostatic urethra

ER Management and What Happens Next

Emergency management is urethral catheterisation: a flexible catheter is passed through the urethra into the bladder, and the retained urine drains immediately. Most men experience near-instant pain relief. If the urethral route fails due to severe obstruction, a suprapubic catheter is inserted directly through the lower abdominal wall into the bladder under local anaesthesia. After catheterisation, the catheter is typically left in place for 24–72 hours. Before removal, most urologists now initiate an alpha-blocker (usually tamsulosin). This 'trial without catheter' (TWOC) succeeds in approximately 50–60% of men — those in whom it fails will need planned surgical intervention.

Prevention: Knowing Your Risk

Men with an IPSS above 7 and a documented weak urinary stream are at elevated lifetime risk of AUR. Medical therapy for symptomatic BPH — particularly 5-alpha reductase inhibitors and combination therapy — reduces the long-term risk of AUR. 5-alpha reductase inhibitors reduce risk further by shrinking the prostate. If you are in this risk group, ensure your urologist has a direct contact pathway for after-hours AUR, understand your personal trigger factors, and avoid high-risk situations (alcohol bingeing, cold exposure, anticholinergic medications) when your symptoms are already worsening.